{
    "SPADE_UN_12123": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_12123",
            "Peptide Name": "B1 (Derived from LL-37 and BMAP-27)",
            "Source": "synthetic construct",
            "Family": "Belongs to the cathelicidin family.",
            "Gene": "Not found",
            "Sequence": "KFKKLFKKLSPVFKRIVQRIKDFLR",
            "Sequence Length": 25,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.31118709] Gram-positive bacteria:Staphylococcus aureus ATCC 29213(MIC=20μM), Staphylococcus aureus ATCC 33591(MIC=20μM), Staphylococcus aureus ATCC 43300(MIC=20μM), Staphylococcus aureus ATCC BAA-41(MIC=20μM);Gram-negative bacteria:Escherichia coli 25922 (MIC=20μM), Escherichia coli 35218 (MIC=20μM), Pseudomonas aeruginosa BAA-2114 (MIC=10μM)",
            "Hemolytic Activity": "[Ref.31118709] 0% hemolysis at 10μM, 8% hemolysis at 25μM, 19% hemolysis at 50μM, 23% hemolysis at 75μM, 30% hemolysis at 100μM, 38% hemolysis at 125μM, 40% hemolysis at 150μM, 43% hemolysis at 175μM, 50% hemolysis at 200μM against human blood cells.",
            "Cytotoxicity": "[Ref.31118709] The cell viability of HEK293 mammalian cell line induced by B1 is 87.0%, 67.1%, 52.3%, 54.3%, 50.6% and 50% at peptide concentrations of 10, 20, 40, 60, 80 and 100 μM.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "The helicity percentages of the secondary structure of B1 are predicted using HNN",
            "Formula": "C153H256N42O30",
            "Mass": 3163.93,
            "PI": 11.77,
            "Net Charge": 9,
            "Hydrophobicity": -0.41,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-nagetive bacteria.",
            "Literature": [
                {
                    "Title": "Design and characterization of a new hybrid peptide from LL-37 and BMAP-27",
                    "Pubmed ID": "31118709",
                    "Reference": "Infect Drug Resist. 2019; 12 1035–1045. Published online 2019 Apr 30. doi 10.2147/IDR.S199473",
                    "Author": "Yara Al Tall, Ahmad Abualhaijaa, Mohammad Alsaggar, Ammar Almaaytah, Majed Masadeh, and Karem H Alzoub",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=31118709"
                }
            ],
            "Frequent Amino Acids": "KFL",
            "Absent Amino Acids": "ACEGHMNOTUWY",
            "Basic Residues": 10,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 12,
            "Polar Residues": 14,
            "Positive Residues": 10,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02482",
                    "Similarity": 1.0,
                    "Sequence": "GRFKRFRKKFKKLFKKLS"
                },
                {
                    "SPADE_ID": "SPADE_UN_11959",
                    "Similarity": 1.0,
                    "Sequence": "KKFKWWWKFKK"
                },
                {
                    "SPADE_ID": "SPADE_UN_15104",
                    "Similarity": 1.0,
                    "Sequence": "GRFKRFRKKFKKLFK"
                }
            ]
        }
    }
}